Kerrie Brady

Kerrie Brady

Company: Occuterra Therapeutics

Job title: Chief Executive Officer

Seminars:

Chair Led Q&A; Making Strides Forward in Drug Delivery & Dosing 12:30 pm

Read more

day: Day One

Non-Invasive Patient Self-Administration – Expanding Therapeutic Options for Patients With Earlier Stage Disease; Making Strides Forward in Drug Delivery & Dosing 12:05 pm

Enabling identification of patients with earlier stage disease through expansion of sophisticated screening and diagnosis technologies employed outside the retinal surgeons offices What advances are in development for patient self-administration that have potential to induce a paradigm shift from the current “watch and wait” management of these patients? Currently available patient administered treatments Existing targets…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.